Earlybird Health

Overview

Earlybird Health is a venture capital firm dedicated to investing in European healthcare innovations that aim to enhance patient outcomes. The firm focuses on a wide range of sectors within the healthcare industry, including digital health, diagnostics, medical devices, R&D tools, and biopharmaceuticals. By supporting these areas, Earlybird Health seeks to drive advancements that positively impact the healthcare landscape across Europe. The firm's investment strategy encompasses various stages of company development, from seed and early-stage investments to growth and late-stage funding. This approach allows Earlybird Health to support companies at different points in their growth trajectory, providing the necessary resources and expertise to scale effectively. The firm's geographical focus spans multiple European countries, reflecting its commitment to fostering innovation throughout the continent. Earlybird Health's track record includes the successful closing of its second fund in February 2024, raising €173 million. This fund is more than twice the size of its predecessor, indicating increased investor interest in healthcare ventures. The firm leverages proprietary tools like EagleEye, an AI and data platform, to enhance its investment processes and gain market intelligence. Additionally, Earlybird Health uniquely includes public health insurers as cornerstone investors, incorporating a payer's perspective into its investment approach.

Investment Focus

• Innovative healthcare solutions
• Strong founding teams
• Scalable business models
• Positive patient impact
• European market focus

Portfolio Companies